Drugs and Devices

FDA approves new melanoma drug

The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have the BRAF V600E mutation. Read more.


Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares